CGX-926

Asset

Corrects mutated MC4R folding and trafficking, restoring receptor function.

Stage
Phase 1
Modality
Small molecule
Target
MC4R
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1
  • Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets